How Far Should the Menthol Ban Go? It's time to ban menthol in cigarettes -- but not necessarily in all tobacco products May 02, 2022
FDA OKs New Nonstimulant Option for Adult ADHD New selective norepinephrine reuptake inhibitor is no longer just for kids May 02, 2022
FDA Proposes Ban on Menthol Cigarettes "Long-awaited action" should reduce youth smoking, health disparities Apr 28, 2022
FDA Approves First Drug for Recurrent Yeast Infections Vivjoa indicated for infertile or postmenopausal women Apr 28, 2022
FDA Issues Warning on Prenatal Genetic Tests Relying on results could lead to inappropriate medical decisions, agency warns Apr 19, 2022
First Topical Therapy for Facial Angiofibroma Nabs FDA Approval New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
ALS Drug Needs More Evidence, FDA Advisors Say But vote was close and panelists remain hopeful about AMX0035 Mar 31, 2022
Another Oral Testosterone Undecanoate OK'd for Hypogonadism FDA approval of Tlando follows in the footsteps of Jatenzo Mar 29, 2022
Novel Fixed-Dose Immunotherapy Combo Wins FDA Approval Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
Medicare Claws Back Money for Dubious Birth-Tissue Stem Cell Shots Government seeks to recoup more than 2 years of payments for unproven treatments Mar 16, 2022
First Generic OK'd for Popular Asthma, COPD Inhaler FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
FDA Warns on Using Surgical Device for Aesthetic Skin Procedures Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancer Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
Rare Vaccine Death; Vape Loophole Exploited; No Paxlovid for the Imprisoned This past week in healthcare investigations Mar 09, 2022
FDA Begins Releasing Pfizer COVID Vax Documents Court-ordered release runs risk of "cherry picking and taking things out of context" Mar 07, 2022
Dr. Bronner's Offering Its Workers Psychedelic Therapy Coverage Soap company to cover ketamine-assisted therapy for employees with new industry nonprofit Mar 01, 2022
Thumbs Down for IV Tramadol, FDA Advisers Say Delayed onset of pain relief remains a concern Feb 16, 2022
FDA OKs 180-Day Implantable Continuous Glucose Monitor Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
FDA Warns of Strangulation Risk for Kids on Feeding Tubes Two toddlers died after being found with enteral feeding systems' tubing around their necks Feb 09, 2022
FDA Concerned About Safety of Lymphoma Drug Hint of excess mortality in trial of umbralisib/ublituximab prompts public notice Feb 03, 2022
FDA Approves First Generic of Restasis for Dry Eye A new option for those affected by keratoconjunctivitis sicca Feb 02, 2022
Another COVID Vaccine Garners Full FDA Approval Moderna's Spikevax approved for adults ages 18 and up Jan 31, 2022
Remdesivir Now Approved for COVID Outpatients, Too FDA expands indication of Veklury to bolster supply of treatment during Omicron surge Jan 22, 2022
FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitis Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
Growing Controversy Over 'Skinny' Labeling for Generic Drugs What's at stake in legal battles over patent-avoiding approval pathway for generics Jan 17, 2022
(When) to Boost or Not to Boost, That Is the Question Countless complex questions remain Jan 13, 2022
Too Much Focus on Boosters, Says FDA Vaccine Advisor At the hospital level, COVID-19 remains "a disease for the unvaccinated," says Paul Offit, MD Jan 12, 2022 video
Why Are Physicians Silent About Outrageous Drug Prices? Milton Packer wonders why physicians are struggling to get their priorities straight Jan 12, 2022
Nose or Throat: What’s Best for a COVID Test? Early data support saliva testing, but it might be too early to tell Jan 06, 2022
FDA OKs Endogenous Cushing's Syndrome Treatment Recorlev reduced and normalized cortisol levels in clinical studies Jan 04, 2022
Alzheimer's Drugs Race to FDA After aducanumab, drug companies pivot to use the accelerated approval pathway Jan 01, 2022
What Happened to the Novavax Vaccine? As mRNA vaccines saturate the U.S. market, is there room for another? Jan 01, 2022
Doctor Submits Fluvoxamine EUA Application to FDA Group of physician-scientists believes data support authorization for treating COVID-19 Dec 29, 2021
IL-13 Inhibitor Approved for Adults With Atopic Dermatitis Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
FDA Approves Cholesterol-Lowering siRNA Therapy PCSK9 inhibitor inclisiran to become available in early 2022 Dec 22, 2021
FDA: The Wait for COVID Pills Is Over Paxlovid first oral antiviral authorized to treat high-risk COVID patients Dec 22, 2021
FDA Approves First Long-Acting Injectable to Prevent HIV Infection Apretude is administered every 2 months versus a daily pill Dec 21, 2021
Is 'Big Pharma' To Blame For the Opioid Crisis? More complex and actionable issues are at the root of the problem Dec 21, 2021
Sapien 3 With Pre-Stent Gets FDA Go-Ahead for Pulmonary Valve Fix Valve system could substantially expand proportion of patients who can skip another surgery Dec 20, 2021
